SCHEMBL15435525

SCHEMBL15435525

COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1C1CCN(C(=O)OC(C)(C)C(=O)OC)CC1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 4/20 0.64
FLT3 P36888 4/20 0.64
RET P07949 3/20 0.64
FRK P42685 3/20 0.64
MAPK9 P45984 3/20 0.64
RPS6KA3 P51812 3/20 0.64
MAP4K2 Q12851 3/20 0.64
PRKCD Q05655 2/20 0.64
BCR P11274 1/20 0.64
DDR1 Q08345 1/20 0.64
TNK1 Q13470 1/20 0.64
RPS6KA1 Q15418 1/20 0.64
MAP3K11 Q16584 1/20 0.64
DDR2 Q16832 1/20 0.64
RPS6KA6 Q9UK32 1/20 0.64
RIPK1 Q13546 3/20 0.41
KDR P35968 11/20 0.37
FLT1 P17948 6/20 0.37
TEK Q02763 4/20 0.37
PDGFRB P09619 4/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL276467 0.94 FGFR1 (0.66) FGFR1FLT3RETFRKMAPK9
SCHEMBL9979888 0.92 FGFR1 (0.63) FGFR1FLT3RETFRKMAPK9
SCHEMBL276552 0.90 FGFR1 (0.67) FGFR1FLT3RETFRKMAPK9
SCHEMBL276616 0.89 FGFR1 (0.69) FGFR1FLT3RETFRKMAPK9
SCHEMBL10225844 0.87 FLT3 (0.49) FGFR1FLT3RETFRKMAPK9
SCHEMBL5182413 0.87 RET (0.56) FGFR1FLT3RETFRKMAPK9
SCHEMBL276273 0.87 FGFR1 (0.69) FGFR1FLT3RETFRKMAPK9
SCHEMBL279530 0.86 FGFR1 (0.61) FGFR1FLT3RETFRKMAPK9
SCHEMBL327903 0.82 FGFR1 (0.60) FGFR1FLT3RETFRKMAPK9
SCHEMBL276489 0.81 FGFR1 (0.73) FGFR1FLT3RETFRKMAPK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8829185-B2 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis BAYER HEALTHCARE LLC (US) 2014-09-09 US disclosed
US-8829185-B2 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis BAYER HEALTHCARE LLC (US) 2014-09-09 US disclosed
EP-1957077-B1 SUBSTITUTED 4-AMINO-PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS BAYER HEALTHCARE LLC (US) 2014-01-22 EP disclosed